Author

E. Hope

University Hospital Southampton NHS Foundation Trust

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Genetic & Genomic Medicine· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Approach:benchmark study· 1 Research Focus:benchmarking· 1 Research Focus:cell type annotation· 1 Assay:electronic health records· 1 Approach:experimental assay· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

A. Cotton· 1 shared Aung OoiD· 1 shared B. Hood· 1 shared C. A. Hamilton· 1 shared D. Cameron· 1 shared D. Tommarello· 1 shared G. L. Maxwell· 1 shared G. McManus· 1 shared

Activity by Year

2019-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperGenetic & Genomic Medicine

A. Cotton

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Barriers to cascade screening in people at risk of Thoracic Aortic Disease: a mixed methods evaluation from the DECIDE-TAD initiative

Riccardo Giuseppe Abbasciano, Joanna Colleen Dionne, Joanne K. Miksza, Simon J. W. Oczkowski, Julian Barwell, Nora L. Shannon, R. Grant, Paul Clift, Riccardo Proietti, E. Hope, U. Ahern, K. Hewytt, L. Ghosh, R. Kaur, M. Lewis, , Gavin James Murphy

This study identifies barriers to cascade screening for thoracic aortic disease using mixed methods, finding low uptake due to awareness, health literacy, and cost concerns.

medRxiv · Dec 2, 2023 · PreprintGenetic & Genomic Medicine

Hematological and Neurological Expressed 1 (HN1): a predictive and pharmacodynamic biomarker of metformin response in endometrial cancers.

N. W. Bateman, P.-n. Teng, E. Hope, B. Hood, J. Oliver, W. Ao, M. Zhou, G. Wang, D. Tommarello, K. Wilson, K. A. Conrads, C. A. Hamilton, K. Darcy, Y. Casablanca, G. L. Maxwell, , T. P. Conrads

This study identifies HN1 as a predictive and pharmacodynamic biomarker of metformin response in endometrioid endometrial cancer, showing it is elevated in responders and decreases after treatment.

bioRxiv · Apr 9, 2019 · PreprintCancer Biology